Literature DB >> 15606378

Counselling in multiple endocrine neoplasia syndromes: from individual experience to general guidelines.

C J Lips1, J W Höppener, B P Van Nesselrooij, R B Van der Luijt.   

Abstract

Counselling of patients and closely related family members has to take a central place in management of hereditary diseases, like multiple endocrine neoplasia (MEN) syndromes including von Hippel-Lindau (VHL) disease. In the strategy of health care, preventive medicine such as periodic clinical examination of families at-risk needs a high priority, because in general it is assumed that continuity in attendance is cost-effective. Counselling has to be based on individual medical experience of the doctor, adjusted to common guidelines and the findings in the family. Information leaflets, appropriate outpatient departments and an extensive network of specialists will facilitate continuity in care. Flow diagrams involving practical guidelines for diagnosis, treatment and follow up need to be applicable and after adjustment, should be accepted generally. Specially trained paramedics for counselling are required as a network that will guarantee periodic clinical examination and secure optimal prevention. Such paramedics will coordinate nationwide multidisciplinary guidance, and organize preventive and emergency cure for these patients. They will be supervised by expert clinicians in the field, and collaborate with specialists for social and psychological issues, patient organizations and clinical genetic centres. All of these professionals are responsible together for providing patients with up to date clinical information (via newsletters, Internet, etc.). Recently, in the Netherlands, a project was initiated to guarantee continuity in care and study the delivery of care. In order to realize this plan, funding has to be provided in the current research programme. In a future system support has to be obtained on a continuous base, preferably by the government and health care insurers and supervised by the national institute for health care.

Entities:  

Mesh:

Year:  2005        PMID: 15606378     DOI: 10.1111/j.1365-2796.2004.01429.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  7 in total

Review 1.  Management of medullary thyroid carcinoma and MEN2 syndromes in childhood.

Authors:  Steven G Waguespack; Thereasa A Rich; Nancy D Perrier; Camilo Jimenez; Gilbert J Cote
Journal:  Nat Rev Endocrinol       Date:  2011-08-23       Impact factor: 43.330

Review 2.  Familial neuroendocrine tumor syndromes: from genetics to clinical practice.

Authors:  Akihiro Sakurai; Miyuki Katai; Kiyoshi Hashizume; Yoshimitsu Fukushima
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

3.  Genetic screening for multiple endocrine neoplasia syndrome type 1 (MEN-1): when and how.

Authors:  Alberto Falchetti
Journal:  F1000 Med Rep       Date:  2010-02-24

Review 4.  Metabologenomics of Phaeochromocytoma and Paraganglioma: An Integrated Approach for Personalised Biochemical and Genetic Testing.

Authors:  Graeme Eisenhofer; Barbara Klink; Susan Richter; Jacques Wm Lenders; Mercedes Robledo
Journal:  Clin Biochem Rev       Date:  2017-04

5.  Pediatric Medullary Thyroid Carcinoma.

Authors:  Dmytro Starenki; Jong-In Park
Journal:  J Pediatr Oncol       Date:  2015

Review 6.  Surgical approach to medullary thyroid carcinoma associated with multiple endocrine neoplasia type 2.

Authors:  Marcos R Tavares; Sérgio P A Toledo; Fábio L M Montenegro; Raquel A Moyses; Rodrigo A Toledo; Tomoko Sekyia; Claudio R Cernea; Lenine G Brandão
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

Review 7.  A differential diagnosis of inherited endocrine tumors and their tumor counterparts.

Authors:  Sergio P A Toledo; Delmar M Lourenço; Rodrigo A Toledo
Journal:  Clinics (Sao Paulo)       Date:  2013-07       Impact factor: 2.365

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.